Both supernatant of LPS-activated MDM and recombinant IFN-β significantly inhibited HIV-1 infection prior to viral DNA synthesis (p<0.005), note that the effective dose of IFN-β was more than 10 times its concentration in the activated MDM supernatant. The gene discussed is IFNB1; the disease is HIV-1 infection.